We evaluated orally administered live attenuated B. melitensis Rev.1 vaccine in combination with flagellin to protect mice against I/P challenge with Brucella melitensis 16M bacteria. Optimal protection was enhanced by three booster immunization doses against challenge at 3 weeks post challenge. Experiments were performed with mice to elucidate the roles of humoral and cell-mediated immune responses in the acquisition of protective immunity to Brucella melitensis and to compare infection immunity with immunity developed through vaccination with oral reduced dose of Rev.1 vaccine of B. melitensis combined with flagellar protein (H7). Vaccination with reduced dose of Rev.1 vaccine orally combined with flagellar protein is better than the vaccination with full dose of Rev.1 vaccine S/C in mice. From the results its pointed out that the cell mediated immunity elicited by the use of oral reduced dose of Rev.1 vaccine (3 Successive) dose combined with flagellar protein.
INTRODUCTION
rucellosis is a serious zoonotic disease caused by different species of genus Brucella characterized by infertility and abortion in animals and a febrile illness (undulant fever) in humans (Corbel et al.,1997) . The disease exists worldwide, especially in Central and South America, India, the Mediterranean basin, the Middle East, and continues to have great health significance and economic importance in these areas (Boschiroli et al., 2001) . In areas where it is endemic, human brucellosis is quite common but often not diagnosed (Marin et al., 1999) (Zvizdic et al., 2006) . At present, the live attenuated Brucella melitensis Rev.1 strain developed by (Elberg S.S.1981 ) is still the only vaccine employed for controlling the caprine brucellosis, as (Scharp et al.1999) mentioned It has been also useful for the control and eradication of this disease. So that, it was used in comprehensive vaccination programs in many countries, including Syria, Saudi-Arabia, Kuwait, Mongolia, Spain, and Turkey (Refai 2002) . However, there are several problems associated with its use in animals. The first issue lies within the fact that Rev.1 contains OPS similar to field strains of B. melitensis and vaccination with this strain leads to the production and persistence of OPS-specific antibodies (Blasco1997). It may induce abortions in pregnant goats (Alton 1987 (Olsen, 2005) . Current vaccines are effective in preventing abortion and transmission of brucellosis, but poor at preventing infection. As Brucella infections occur mainly through mucosal surfaces, the development of mucosal administered vaccines could be radical for the control of brucellosis (Arenas et al., 2000 
MATERIALS AND METHODS

Experimental animals
Males white BALB C mice: Total number of (200) BALB C Mice of about (30) grams were used. The mice were fed a balanced commercial ration. All animals provided were proved to be Brucella free by serotesting (Rose Bengal Test, Buffered Acidified Plate Antigen Test). These animals were divided into (5) A vaccinal strain was kindly obtained from seed strain (obtained from National Veterinary Services Laboratories "NVSL", 1800 Dayton Avenue, Ames, Iowa, 50010, USA).
2.2.1.2.Brucella melitensis strain 16M:
It was supplied by USDA, USA, National Veterinary Services Laboratories "NVSL", Ames, Iowa, 50010. Strains (3.1.2.1, 3.1.2.2., 3.1.2.3) were reconstituted in 10 ml diluent (0.75 M NaCl, pH 6.4).
2.2.1.3.Brucella abortus strain RB51:
Brucella abortus strain RB51 a vaccinal strain, is kindly provided by private cattle farm, lyophilized vaccine vials of 5 doses, each and the dose of (3.4×10 10 CFU), lyophilized vaccine, serial No. 1472, Professional Biological Company, 4950 York St., Denver, Colorado 8021. USA. The vaccine vial was reconstituted in 10 ml diluent (0.15M NaCl, pH 6.4).
E. coli O157:H7 (EHEC):
Strains was tested and confirmed by standard technique. The strain was kindly provided by serological Unit of Animal Health Research Institute, Dokki, and Giza, Egypt. Preparation of H7 flagellin: H7 flagellin was prepared and examined by SDS-PAGE as described in (He and Keel, 1994) . Purified flagellin H7 protein was determined. Western Blot Procedure: (Towbin et al., 1979) . Western blot allows to determine the molecular weight of a protein and to measure relative amounts of the protein present to different samples in lanes.
2.4.Brucella antigens:
2.4.1. Rose Bengal Antigen: Prepared in VSVRI, Abbasia, Cairo accpording to Alton et al. (1988) .
Tube Agglutination Antigen (B.
abortus): Prepared in VSVRI, Abbasia, Cairo, according to Alton et al. (1988) .
2.5.Brucella vaccine:
Brucella melitensis Rev.1 vaccine prepared in VSVRI, Abbasia, Cairo, according to Alton et al. (1988 Araya et al., 1989) ; A total of 30 white mice (BALB C mice) was sensitized by an oral local prepared Rev.1 mixed with flagellin gave 3 doses interval 1 week fifteen days after vaccination, the left and right flanks of mice were cleanly shaved and each mouse was injected I/D with 0.1 ml RB51 brucellin, each diluted 1:10,1:20,1:100. The diameter of the erythema zone at the injection of Brucellin was measured with caliper 24 hr. and 48hr. after the I/D injection.
Culture media:
Tryptone soya agar: Tryptone soya agar medium with bovine serum 5-10 % prepared according to method of Alton et al. (1988) .
2.8.Potency test for (G1-G5):
Challenged mice 3weeks after vaccination intraperitoneally with 5 x 10 8 CFU of (B. melitensis 16M) or (E.coli). All mice in each group were slaughtered 3 weeks after challenge. According to OIE (2000) .
RESULTS
Protection assay
To analyze the vaccines efficacy of different groups mice against virulent B.melitensis 16 M oral challenge infections, or in vivo protection study in mice was performed. In this experiment, protection was defined as significant reductions in the mice receive the different type's vaccines.
The vaccine efficacy was calculated according to OIE (2000) as response and protection mice 2.5, standard deviation calculated each group of mice is lower mean 0.8. Table ( 3) and Fig (1) shows that mice G3 immunized with Oral reduce dose of Rev.1 vaccine and flagellin gave 3 succive doses at I week interval gave lower of number of Brucella count mean (237.94 CFU / spleen) and protection (P) 1.99 ≠ 0.106 against B.melitensis 16M challenge. Table ( 
Result of cell mediated immune response of mice judged by skin delayed hyper sensitivity test (SDHT):
DISCUSSION
Brucella is intracellular pathogens, these bacteria exquisitely well adapted to survival and replication inside eukaryotic cells which is one of the basis for the well-known but still poorly explained chronically Table ( 2): Groups of experimental animals (BALB C-mice)
Group (1) Group (2) Group (3) Group (4) Group (5) Type of injected materials (Ficht,2003) (Lix, et al.,2012 ) a total of 30 flagellar genes of Brucella abortus were selected for in vitro expression and 15 of these flagellar genes were successfully expressed as this tagged recombinant protein in E.coli ER 25 bb, these proteins were purified and used to analyze their T. cell immunity. (Fretin et al., 2005 ) Brucella melitensis has all the genes needed for and is effectively able to construct a complete flagellar structure. In this study showed that immunization with E.coli flagellin and Rev.1 orally in mice could provide protection against wild strain B.melitensis 16M infection from these study suggested that flagellin proteins were protective antigens that could produce humoral and cell-mediated in mice. CFU I/P are presented in table (3). All groups were challenged after 3 weeks from vaccination G3 of mice gave higher protection log 1.99+0.106 and lower mean bacterial counts /spleen. The results of potency test clearly demonstrated that vaccinated with 3 oral reduced dose (Rev.1) 10 7 CFU) with flagellin was the best vaccination programme for control of brucellosis. In this study, reported that oral reduce dose table (3) showed high protection when compared to G1 vaccinated with S/C full dose Rev.1 (10 8 CFU). Oral flagellin in mice G2 display lower protection against challenge by B. melitensis 16M (table 1) .
